Doctor profile · Federal record
Dr. JOHN HEMMERSMEIER, MD
Family Medicine Physician (CMS: FAMILY PRACTICE) · OGDEN, UT
- NPI 1073582995
- Accepts Medicare
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5740 CRESTWOOD DR
OGDEN, UT 844054869
(801) 479-7771
fax (801) 479-7795 - Mailing address
-
PO BOX 5546
DENVER, CO 802175546
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- January 18, 2017
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- Utah #5673889-1205
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1073582995. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,316
Distinct HCPCS
10
Medicare allowed
$473,330
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 2,050 | 619 | $121 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,508 | 577 | $7 | |
80053 |
Blood test, comprehensive group of blood chemicals | 992 | 511 | $10 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 944 | 520 | $8 | |
84443 |
Blood test, thyroid stimulating hormone (tsh) | 569 | 425 | $16 | |
80061 |
Blood test, lipids (cholesterol and triglycerides) | 487 | 396 | $13 | |
83036 |
Hemoglobin a1c level | 401 | 161 | $10 | |
G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 397 | 397 | $122 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 313 | 91 | $6 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 223 | 34 | $1 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 87. This provider delivers 130× the peer median.Open Payments
Industry payments received
All-time total
$914
Transactions
38
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen Inc. | 9 | $319.90 | |
| ABBVIE INC. | 8 | $141.07 | |
| AstraZeneca Pharmaceuticals LP | 4 | $81.41 | |
| Phathom Pharmaceuticals, Inc. | 2 | $41.77 | |
| Novartis Pharmaceuticals Corporation | 2 | $40.12 | |
| Novo Nordisk Inc | 2 | $38.24 | |
| Lilly USA, LLC | 2 | $35.23 | |
| Merck Sharp & Dohme LLC | 1 | $35.00 | |
| Edwards Lifesciences Corporation | 1 | $28.88 | |
| Astellas Pharma US Inc | 1 | $27.28 | |
| Boston Scientific Corporation | 1 | $25.41 | |
| Dexcom, Inc. | 1 | $22.84 | |
| Exact Sciences Corporation | 1 | $22.44 | |
| PFIZER INC. | 2 | $22.26 | |
| IDORSIA PHARMACEUTICALS US INC | 1 | $18.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
5,457
Patients
1,627
Total drug cost
$93,884
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 790 | 228 | $11,360 |
| Levothyroxine Sodium | Generic | 651 | 167 | $14,069 |
| Losartan Potassium | Generic | 592 | 181 | $10,790 |
| Omeprazole | Generic | 498 | 157 | $9,790 |
| Amlodipine Besylate | Generic | 487 | 155 | $4,731 |
| Lisinopril | Generic | 442 | 125 | $4,958 |
| Hydrochlorothiazide | Generic | 300 | 94 | $1,458 |
| Rosuvastatin Calcium | Generic | 284 | 96 | $6,251 |
| Gabapentin | Generic | 250 | 82 | $6,783 |
| Metformin Hcl | Generic | 222 | 61 | $2,623 |